Nurse led telephone monitoring of Growth Hormone treatment
Research type
Research Study
Full title
Application of Web-based Adherence Information integrated Nurse-led Monitoring Clinic (WAIN-MC) for Growth Hormone treatment in children
IRAS ID
264053
Contact name
Indraneel Banerjee
Contact email
Sponsor organisation
Manchester University NHS Foundation Trust
Duration of Study in the UK
2 years, 5 months, 30 days
Research summary
Growth Hormone treatment is given to children for a number of conditions including growth hormone deficiency. Treatment depends on giving a daily injection of growth hormone using a special device for several years. The response of growth hormone treatment depends on a number of factors; one important factor is adherence to daily injections. While daily injections of an expensive growth hormone are prescribed over several years by doctors, it is recognised that patients and families often forget to inject medication with loss of adherence. At present, most devices used to administer growth hormone do not enable monitoring or help reinforce adherence, except for the eadypod device.
The easypod device records daily injections and has the ability to connect to a web-based secure system using easypod connect. Easypod connect provides paediatric endocrine specialist nurses adherence data that they can discuss with families to reinforce and therefore improve adherence.
In Manchester, it is standard clinical practice to undertake telephone growth clinics (nurse-led monitoring clinics) by paediatric endocrine specialist nurses. Such clinics provide good quality of care to assess growth performance without the need to attend the hospital. We hypothesise that web-based adherence data may be combined with nurse-led monitoring clinics as a clinical innovation called web-based adherence information integrated nurse-led monitoring clinic (WAIN-MC).
WAIN-MC will be tested as a pilot study in a single centre in Manchester. The study will find out if the WAIN-MC model is feasible, whether it provides better growth outcomes in children than previously and if this model could be extended more widely.
REC name
West Midlands - Solihull Research Ethics Committee
REC reference
19/WM/0277
Date of REC Opinion
9 Dec 2019
REC opinion
Further Information Favourable Opinion